Koos P J van Dam

Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies

Laura Boekel, Maurice Steenhuis, Femke Hooijberg et al. · The Lancet Rheumatology · 2021 · 170 citations · Full text

Adverse events after first COVID-19 vaccination in patients with autoimmune diseases

Laura Boekel, Laura Kummer, Koos P J van Dam et al. · The Lancet Rheumatology · 2021 · 79 citations · Full text

Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases

Luuk Wieske, Laura Kummer, Koos P J van Dam et al. · BMC Medicine · 2022 · 25 citations · Full text

Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases

Eileen W Stalman, Luuk Wieske, Koos P J van Dam et al. · Annals of the Rheumatic Diseases · 2022 · 23 citations · Full text

Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations

Koos P J van Dam, Luuk Wieske, Eileen W Stalman et al. · Journal of Autoimmunity · 2023 · 23 citations · Full text

Vaccination, Vaccine Development, Vaccine Target +7